| Manoj Kumar, MD | |
|
64 Pomeroy St, Cortland, NY 13045-2708 | |
| (607) 753-6560 | |
| (607) 753-6757 |
| Full Name | Manoj Kumar |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 35 Years |
| Location | 64 Pomeroy St, Cortland, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013922335 | NPI | - | NPPES |
| 02806619 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 241226 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cayuga Medical Center At Ithaca | Ithaca, NY | Hospital |
| Guthrie Cortland Regional Medical Center | Cortland, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cortland Ent, Pc | 5698864429 | 6 |
News Archive
Researchers in China have demonstrated interferon-alpha (IFN-α) is associated with increased risk of atherosclerosis in patients with systemic lupus erythematosus (SLE). For the first time, IFN-α priming was shown to promote lipid uptake and foam cell formation—a crucial step in plaque build-up. This activation of the IFN signaling pathway may be linked to the premature atherosclerosis risk in SLE.
The nation's health care spending is slated to rise about 6 percent next year, according to a new Centers for Medicare & Medicaid Services report. This follows five years of slower growth expected to end as the nation's economy recovers and the health law expands coverage. The spending increase is likely lower than it would have been, however, if the Supreme Court hadn't allowed states to choose whether to expand Medicaid, researchers wrote.
New research finds that a protein that is often mutated in Huntington's disease (HD) plays an unexpected role in the process of neurogenesis. The research, published by Cell Press in the August 12 issue of the journal Neuron, provides new insight into HD pathology and has even broader implications for human health and disease.
Discovery Laboratories, Inc., a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has initiated its AEROSURF phase 2b clinical trial in premature infants 26 to 32 weeks gestational age (GA) receiving non-invasive nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS).
› Verified 6 days ago
| Entity Name | Cortland Ent, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417144239 PECOS PAC ID: 5698864429 Enrollment ID: O20071203000071 |
News Archive
Researchers in China have demonstrated interferon-alpha (IFN-α) is associated with increased risk of atherosclerosis in patients with systemic lupus erythematosus (SLE). For the first time, IFN-α priming was shown to promote lipid uptake and foam cell formation—a crucial step in plaque build-up. This activation of the IFN signaling pathway may be linked to the premature atherosclerosis risk in SLE.
The nation's health care spending is slated to rise about 6 percent next year, according to a new Centers for Medicare & Medicaid Services report. This follows five years of slower growth expected to end as the nation's economy recovers and the health law expands coverage. The spending increase is likely lower than it would have been, however, if the Supreme Court hadn't allowed states to choose whether to expand Medicaid, researchers wrote.
New research finds that a protein that is often mutated in Huntington's disease (HD) plays an unexpected role in the process of neurogenesis. The research, published by Cell Press in the August 12 issue of the journal Neuron, provides new insight into HD pathology and has even broader implications for human health and disease.
Discovery Laboratories, Inc., a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has initiated its AEROSURF phase 2b clinical trial in premature infants 26 to 32 weeks gestational age (GA) receiving non-invasive nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Manoj Kumar, MD 64 Pomeroy St, Cortland, NY 13045-2708 Ph: (607) 753-6560 | Manoj Kumar, MD 64 Pomeroy St, Cortland, NY 13045-2708 Ph: (607) 753-6560 |
News Archive
Researchers in China have demonstrated interferon-alpha (IFN-α) is associated with increased risk of atherosclerosis in patients with systemic lupus erythematosus (SLE). For the first time, IFN-α priming was shown to promote lipid uptake and foam cell formation—a crucial step in plaque build-up. This activation of the IFN signaling pathway may be linked to the premature atherosclerosis risk in SLE.
The nation's health care spending is slated to rise about 6 percent next year, according to a new Centers for Medicare & Medicaid Services report. This follows five years of slower growth expected to end as the nation's economy recovers and the health law expands coverage. The spending increase is likely lower than it would have been, however, if the Supreme Court hadn't allowed states to choose whether to expand Medicaid, researchers wrote.
New research finds that a protein that is often mutated in Huntington's disease (HD) plays an unexpected role in the process of neurogenesis. The research, published by Cell Press in the August 12 issue of the journal Neuron, provides new insight into HD pathology and has even broader implications for human health and disease.
Discovery Laboratories, Inc., a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has initiated its AEROSURF phase 2b clinical trial in premature infants 26 to 32 weeks gestational age (GA) receiving non-invasive nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS).
› Verified 6 days ago